Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1995-10-31
1999-10-12
Adams, Donald E.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 9, 530321, 530317, A61K 3812
Patent
active
059655267
ABSTRACT:
Cyclic pentapeptides are disclosed having the following formula (I) --Cyclo(-A.sub.1 -A.sub.2 -A.sub.3 -A.sub.4 -A.sub.5 -)-- wherein A.sub.1, A.sub.2, A.sub.3, A.sub.4 and A.sub.5, are amino acid residues. The pentapeptide has amino acid residues in positions 1-2-3 to form a .gamma.-turn, and amino acid residues in positions 3-4-5-1 to form a .beta.-turn in combination with the .gamma.-turn. D-.alpha.-amino acid residues are selected for A.sub.1, A.sub.3, and A.sub.5 and L-.alpha.-amino acid residues are selected for A.sub.2 and A.sub.4. Compounds having .gamma.-turns and .beta.-turns can be synthesized, regardless of the kinds of amino acid residues, and it is possible to synthesize compounds in which desired amino acid residues are introduced into sites of .beta.-turn and .gamma.-turn based on their importance from the viewpoint of biological activity. The present invention is therefore available for design of compounds having biological activity.
REFERENCES:
patent: 5114918 (1992-05-01), Ishikawa et al.
J. Antibiotics, vol. 44, No. 12, Dec. 1991--pp. 1348-1356.
J. Antibiotics, vol. 45, No. 5, May 1992--pp. 788-791.
Int. J. Peptide Protein Res., vol. 20, 1982--pp. 16-25.
Liebigs Ann. Chem., vol. 5, 1986--pp. 869-892.
Chemical Abstracts, vol. 117, No. 15 Abstract No. 143998.
J. Med. Chem. vol. 33 1990--pp. 2552-2560.
FEBS Letters, 296, pp. 1-6, 1992.
FEBS Letters, 299, pp. 255-261, 1992.
Gu et el, Biochemical & Biophysical Research Comm; vol. 179(1), pp. 130-133 (Aug. 30, 1991).
Ihara et al, Biochemical & Biophysical Res. Com., vol. 178(1), pp. 132-137 (Jul. 15, 1991).
Rovero et al, Peptides, vol. 11, pp. 619-620, (1990).
Holzeman, Peptide Conformation Mimetics, pp. 3-12.
Buck et al, Life Sciences, vol. 42, pp. 2701-2708, (1988).
Feigel, J. Am. Chem. Soc., vol. 108, pp. 181-182, (1986).
Endo Satoshi
Inooka Hiroshi
Kikuchi Takashi
Wakimasu Mitsuhiro
Adams Donald E.
Conlin David G.
Neuner George W.
Takeda Chemical Industries, Inc.
Wessendorf T. D.
LandOfFree
Pentapeptide with specific conformation, its production and use does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pentapeptide with specific conformation, its production and use, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pentapeptide with specific conformation, its production and use will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-652382